Insider Trading activities of Atherogenics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Atherogenics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Atherogenics Inc since year 2005. Table 2 shows the detailed insider transactions of Atherogenics Inc since 2005. The reporting company's ticker symbol is AGIX. The reporting company's CIK number is 1107601.
The total value of stock buying since 2005 is $29,425,474.
The total value of stock sales since 2005 is $7,949,201.
The total value of stock option exercises since 2005 is $535,875.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Atherogenics Inc (AGIX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2009-02 0 $0 26,000 $910 0 $0
2008-10 0 $0 100,000 $6,300 0 $0
2008-02 50,000 $32,000 0 $0 0 $0
2008-01 25,000 $9,750 3,386 $1,320 0 $0
2007-12 0 $0 113,562 $47,608 0 $0
2007-11 0 $0 1,962,990 $1,093,394 0 $0
2007-08 0 $0 55,518 $119,363 10,000 $3,000
2007-06 0 $0 0 $0 10,000 $3,000
2007-04 36,000 $99,576 0 $0 0 $0
2007-03 0 $0 0 $0 25,000 $9,500
2007-01 0 $0 0 $0 12,000 $4,560
2006-08 1,000 $14,115 0 $0 0 $0
2006-06 40,000 $520,421 0 $0 0 $0
2006-05 24,000 $330,998 0 $0 0 $0
2006-04 3,000 $42,090 0 $0 48,100 $369,471
2006-03 1,000 $15,827 41,800 $640,041 0 $0
2006-02 225,000 $3,876,750 0 $0 0 $0
2006-01 375,000 $6,342,500 0 $0 0 $0
2005-12 0 $0 295,000 $6,040,265 116,100 $146,344
2005-10 250,000 $3,887,000 0 $0 0 $0
2005-06 200,000 $3,196,500 0 $0 0 $0
2005-05 424,900 $5,805,662 0 $0 0 $0
2005-03 379,800 $5,252,285 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Atherogenics Inc insiders (AGIX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-02-04 Barker Sam L (Director) Sale 26,000 .04 910
2008-10-31 Henos Michael A (Director) Sale 100,000 .06 6,300
2008-02-08 Bryson Vaughn D (Director) Buy 50,000 .64 32,000
2008-01-25 Barker Sam L (Director) Buy 25,000 .39 9,750
2008-01-22 Bryson Vaughn D (Director) Sale 3,386 .39 1,320
2007-12-28 Bryson Vaughn D (Director) Sale 24,733 .38 9,448
2007-12-27 Bryson Vaughn D (Director) Sale 48,732 .40 19,492
2007-12-26 Bryson Vaughn D (Director) Sale 2,440 .40 976
2007-12-20 Bryson Vaughn D (Director) Sale 7,657 .43 3,292
2007-12-06 Henos Michael A (Director) Sale 30,000 .48 14,400
2007-11-28 Barakett Timothy R (10% Owner) Sale 1,679,949 .54 908,852
2007-11-27 Barakett Timothy R (10% Owner) Sale 283,041 .65 184,542
2007-08-29 Bryson Vaughn D (Director) Sale 55,518 2.15 119,363
2007-08-01 Medford Russell M (President & CEO) Option Ex 10,000 .30 3,000
2007-06-05 Medford Russell M (President & CEO) Option Ex 10,000 .30 3,000
2007-04-02 Scott Robert A (Exec VP Research & Development) Buy 36,000 2.77 99,576
2007-03-20 Colonnese Mark P (Exec VP, Commercial Operations) Option Ex 25,000 .38 9,500
2007-01-19 Dagi T. Forcht (Director) Option Ex 12,000 .38 4,560
2006-08-31 Barker Samuel L (Director) Buy 1,000 14.12 14,115
2006-06-30 Bryson Vaughn D (Director) Buy 17,132 13.06 223,778
2006-06-29 Bryson Vaughn D (Director) Buy 22,868 12.97 296,643
2006-05-30 Bryson Vaughn D (Director) Buy 20,000 13.87 277,460
2006-05-24 Pappas Arthur M (Director) Buy 1,000 12.97 12,969
2006-05-22 Pappas Arthur M (Director) Buy 3,000 13.52 40,569
2006-04-27 Bearman David (Director) Option Ex 45,600 8.09 368,721
2006-04-27 Pappas Arthur M (Director) Buy 3,000 14.03 42,090
2006-04-12 Medford Russell M (President & CEO) Option Ex 2,500 .30 750
2006-03-24 Pappas Arthur M (Director) Buy 1,000 15.83 15,827
2006-03-16 Scott William A (Director) Sale 41,800 15.31 640,041
2006-02-01 Barakett Timothy R (10% Owner) Buy 225,000 17.23 3,876,750
2006-01-31 Barakett Timothy R (10% Owner) Buy 250,000 16.94 4,235,000
2006-01-30 Barakett Timothy R (10% Owner) Buy 125,000 16.86 2,107,500
2005-12-28 Scott Robert A (Sr VP Clinical Dev &) Sale 20,000 20.01 400,140
2005-12-28 Scott Robert A (Sr VP Clinical Dev &) Option Ex 16,100 7.04 113,344
2005-12-28 Medford Russell M (President & CEO) Sale 150,000 20.02 3,003,000
2005-12-28 Alexander R Wayne (Director) Sale 25,000 20.08 502,125
2005-12-27 Colonnese Mark P (Sr VP Finance & Admi) Sale 100,000 21.35 2,135,000
2005-12-27 Colonnese Mark P (Sr VP Finance & Admi) Option Ex 100,000 .33 33,000
2005-10-27 Barakett Timothy R (10% Owner) Buy 30,000 15.27 458,100
2005-10-24 Barakett Timothy R (10% Owner) Buy 50,000 15.30 765,000
2005-10-21 Barakett Timothy R (10% Owner) Buy 80,000 15.36 1,228,400
2005-10-17 Barakett Timothy R (10% Owner) Buy 90,000 15.95 1,435,500
2005-06-14 Barakett Timothy R (10% Owner) Buy 50,000 16.32 816,000
2005-06-10 Barakett Timothy R (10% Owner) Buy 50,000 16.44 822,000
2005-06-09 Barakett Timothy R (10% Owner) Buy 100,000 15.58 1,558,500
2005-05-27 Barakett Timothy R (10% Owner) Buy 50,000 14.63 731,500
2005-05-25 Barakett Timothy R (10% Owner) Buy 100,000 14.80 1,479,500
2005-05-18 Barakett Timothy R (10% Owner) Buy 49,900 14.63 730,037
2005-05-06 Barakett Timothy R (10% Owner) Buy 100,000 13.69 1,369,000
2005-05-05 Barakett Timothy R (10% Owner) Buy 125,000 11.96 1,495,625
2005-03-28 Barakett Timothy R (10% Owner) Buy 100,000 13.83 1,383,000
2005-03-24 Barakett Timothy R (10% Owner) Buy 129,800 14.07 1,826,286
2005-03-22 Barakett Timothy R (10% Owner) Buy 150,000 13.62 2,042,999

Insider trading activities including stock purchases, stock sales, and option exercises of AGIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Atherogenics Inc (symbol AGIX, CIK number 1107601) see the Securities and Exchange Commission (SEC) website.